1. (a) Commercial feed, other than customer-formula feed, shall be labeled with the following information on the principal display panel of the product and in the following format:

   1. (1) Product name and brand name, if any, as stipulated in Agr 1202.03(a);
   2. (2) If a drug is used, label as stipulated in Agr 1202.03(b);
   3. (3) Purpose statement as stipulated in Agr 1202.03(c);
   4. (4) Guaranteed analysis as stipulated in Agr 1202.03(d) through (q);
   5. (5) Feed ingredients as stipulated in Agr 1202.03(r);
   6. (6) Directions for use and precautionary statements as stipulated in Agr 1202.03(s);
   7. (7) Name and principal mailing address of manufacturer or persons responsible for distributing the feed as stipulated in Agr 1202.03(t); and
   8. (8) Quantity statement as stipulated in Agr 1202.03 (u).
2. (b) The information required in Agr 1202.02 (a)(1) through (3) and (8) shall appear in its entirety on one side of the label or on one side of the container.
3. (c) The information as required in Agr 1202.02(a)(4) through (7) shall be displayed in a prominent place on the feed label or container, but not necessarily on the principal display panel.
4. (d) When the information as required in Agr 1202.02(a)(6) does not appear on the principal display panel, it must be referenced on the principal display panel with a statement such as “See back of label for directions for use.”.
5. (e) None of the information required by Agr 1202.02(a) shall be subordinated or obscured by other statements or designs.

6. (f) Customer-formula feed shall be accompanied with labels, invoices, delivery tickets, or other shipping documents bearing the following information:

   1. (1) The name and address of the manufacturer;
   2. (2) The name and address of the purchaser;
   3. (3) The date of sale or delivery;
   4. (4) The customer-formula feed name and brand name if any;
   5. (5) The product name and net quantity of each registered commercial feed and each other ingredient used in the mixture;
   6. (6) The direction for use and precautionary statements as required by Agr 1202.06; and

   7. (7) If a drug containing product is used:

      1. a. The purpose of the medication, or claim statement; and
      2. b. The established name of each active drug ingredient and the level of each drug used in the final mixture expressed in accordance with Agr 1202.04(d).

Source. #2075, eff 8-1-82; ss by #2825, eff 8-20-84; EXPIRED 8-20-92 New. #5488, eff 10-15-92, EXPIRED: 10-15-98 New. #7054, eff 7-20-99, EXPIRED: 7-20-07 New. #12487, INTERIM, eff 3-1-18, EXPIRED: 8-28-18 New. #12788, eff 5-23-19